Adenike Atanda
Research Subjects
Research Interests
Adenike Atanda has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Abigail L. Hulsizer
College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA
1 shared publication - Brittany Palasik Torres
College of Pharmacy, The University of North Texas Health Science Center, Fort Worth, TX, USA
1 shared publication - Crystal K. Howell
UNT Health Fort Worth College of Pharmacy Fort Worth Texas USA
1 shared publication Kayla Riley
Osteopathic Medicine Student OMS III, Texas College of Osteopathic Medicine, 3500 Camp Bowie Blvd, Fort Worth, TX, 76107, USA
1 shared publication- Rolake Neba
Department of Pharmacotherapy, College of Pharmacy, UNT Health, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA
1 shared publication Taylor M. Benavides
University of North Texas Health Science Center College of Pharmacy, Fort Worth, Texas, United States
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by Springer Nature in Annals of Hematology
- Vol. 105 (11)
Evaluation of non-opioid therapies for pain management of sickle cell disease: a literature-based review
Pain is a debilitating complication of sickle cell disease (SCD), driven by recurrent vaso-occlusive crises and chronic pain syndromes involving central sensitization and neuropathic mechanisms. Although opioid medications remain first-line therapy for acute pain, there are limitations that highlight the need for effective adjunctive approaches. Available data support non-opioid pharmacologic therapies including acetaminophen and nonsteroidal anti-inflammatory drugs as components of multimodal analgesia, with emerging evidence for therapies targeting neuropathic and centralized pain. Non-pharmacologic interventions such as cognitive behavioral therapy have also demonstrated potential benefits as adjunctive strategies in SCD pain management. This literature review examines evidence supporting non-opioid pharmacologic and non-pharmacologic therapies for pain management in SCD and is based on structured searches of PubMed, MEDLINE, and Cochrane databases.
- 10 July 2026
- Published by Springer Nature in Annals of Hematology
- Vol. 105 (11)
Open AccessEvaluation of non-opioid therapies for pain management of sickle cell disease: a literature-based review
Pain is a debilitating complication of sickle cell disease (SCD), driven by recurrent vaso-occlusive crises and chronic pain syndromes involving central sensitization and neuropathic mechanisms. Although opioid medications remain first-line therapy for acute pain, there are limitations that highlight the need for effective adjunctive approaches. Available data support non-opioid pharmacologic therapies including acetaminophen and nonsteroidal anti-inflammatory drugs as components of multimodal analgesia, with emerging evidence for therapies targeting neuropathic and centralized pain. Non-pharmacologic interventions such as cognitive behavioral therapy have also demonstrated potential benefits as adjunctive strategies in SCD pain management. This literature review examines evidence supporting non-opioid pharmacologic and non-pharmacologic therapies for pain management in SCD and is based on structured searches of PubMed, MEDLINE, and Cochrane databases.
- Open Access
- 21 January 2023
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 23 (1) , 127-131
Innovative approach to career pathway mentorship for pharmacy postgraduate training
Introduction: This brief describes the results of two initiatives, a Postgraduate Training Seminar elective course and a P4 Postgraduate Mentorship Programme, on pharmacy residency match rates at a College of Pharmacy. Description of programmes: The Postgraduate Training Seminar elective course was developed to aid third-year pharmacy students interested in residency. The P4 Postgraduate Mentorship Programme was founded to help fourth-year students interested in postgraduate job attainment. Evaluation: For students participating in the elective, College of Pharmacy residency match rates varied in comparison to the national rates (2019: 55% vs 63%; 2020: 67% vs 65%; 2021: 94% vs 77%). In 2021, students who participated in both the elective course and mentorship programme achieved the highest match results compared to the national rate (2019: 38% vs 63%; 2021: 55% vs 77%). Future plans: Both initiatives will continue, with plans for the expansion of mentorship into the earlier years of the curriculum.
- 21 January 2023
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 23 (1) , 127-131
Open AccessInnovative approach to career pathway mentorship for pharmacy postgraduate training
Introduction: This brief describes the results of two initiatives, a Postgraduate Training Seminar elective course and a P4 Postgraduate Mentorship Programme, on pharmacy residency match rates at a College of Pharmacy. Description of programmes: The Postgraduate Training Seminar elective course was developed to aid third-year pharmacy students interested in residency. The P4 Postgraduate Mentorship Programme was founded to help fourth-year students interested in postgraduate job attainment. Evaluation: For students participating in the elective, College of Pharmacy residency match rates varied in comparison to the national rates (2019: 55% vs 63%; 2020: 67% vs 65%; 2021: 94% vs 77%). In 2021, students who participated in both the elective course and mentorship programme achieved the highest match results compared to the national rate (2019: 38% vs 63%; 2021: 55% vs 77%). Future plans: Both initiatives will continue, with plans for the expansion of mentorship into the earlier years of the curriculum.